Financhill
Buy
53

APLS Quote, Financials, Valuation and Earnings

Last price:
$32.99
Seasonality move :
14.66%
Day range:
$32.89 - $34.27
52-week range:
$24.34 - $73.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.71x
P/B ratio:
17.40x
Volume:
3.6M
Avg. volume:
3.6M
1-year change:
-39.64%
Market cap:
$4.1B
Revenue:
$396.6M
EPS (TTM):
-$2.03

Earnings Data

Next earnings date for APLS
Feb 27
2025
Most recent earnings per share
-$0.46
Missed by $0.19
(Nov 5/2024)
Consensus Estimate
-$0.27
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

APLS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2025 Q4 $193.1M -- -- -$0.37 --
11/05/2024 Q3 $199.8M $196.8M -$0.46 -$0.27 -$0.19
08/01/2024 Q2 $191.3M $199.7M -$0.30 -$0.32 $0.02
05/07/2024 Q1 $164.3M $172.3M -$0.54 -$0.41 -$0.13
02/27/2024 Q4 $143.6M $146.4M -$0.73 -$0.70 -$0.03
11/01/2023 Q3 -- -- -$1.17 -$0.99 -$0.18
07/31/2023 Q2 -- -- -$1.02 -$1.34 $0.32
05/04/2023 Q1 -- -- -$1.56 -$1.46 -$0.10
02/21/2023 Q4 -- -- -$1.50 -$1.45 -$0.05
11/07/2022 Q3 -- -- -$1.75 -$1.43 -$0.32
08/08/2022 Q2 -- -- -$1.46 -$1.36 -$0.10
05/04/2022 Q1 -- -- -$1.42 -$1.19 -$0.23
02/28/2022 Q4 -- -- -$1.53 -$1.60 $0.07
11/08/2021 Q3 -- -- -$2.28 -$1.57 -$0.71
08/09/2021 Q2 -- -- -$2.72 -$1.66 -$1.06
04/28/2021 Q1 -- -- -$2.32 -$1.76 -$0.56
02/25/2021 Q4 -- -- $1.06 -$1.37 $2.43
11/02/2020 Q3 -- -- -$1.79 -$1.56 -$0.23
07/31/2020 Q2 -- -- -$1.57 -$1.35 -$0.22
05/08/2020 Q1 -- -- -$2.29 -$1.43 -$0.86
02/27/2020 Q4 -- -- -$2.11 -$1.16 -$0.95
11/05/2019 Q3 -- -- -$1.10 -$1.04 -$0.06
07/31/2019 Q2 -- -- -$0.98 -$0.74 -$0.24
05/08/2019 Q1 -- -- -$0.84 -$0.62 -$0.22
02/26/2019 Q4 -- -- -$0.65 -$0.68 $0.03
11/13/2018 Q3 -- -- -$0.63 -$0.69 $0.06
07/31/2018 Q2 -- -- -$0.61 -$0.42 -$0.19
04/30/2018 Q1 -- -- -$0.43 -$0.33 -$0.10
03/19/2018 Q4 -- -- -$0.60 -$0.48 -$0.12
09/30/2017 Q3 -- -- -$0.23 -$0.24 $0.01

Apellis Pharmaceuticals Earnings Questions

  • How Much did Apellis Pharmaceuticals Generate in Revenue Last Quarter?

    Apellis Pharmaceuticals reported $196.8M worth of top line sales in its most recent quarter.

  • Did Apellis Pharmaceuticals Beat Earnings Last Quarter?

    Apellis Pharmaceuticals announced earnings per share of -$0.46 which represents a miss of analyst forecast a -$0.27 per share.

  • Is Apellis Pharmaceuticals Profitable?

    Apellis Pharmaceuticals reported $163.3M that represents $1.31 per share over the last quarter.

  • What is the Analyst Consensus for Apellis Pharmaceuticals EPS Next Year?

    Apellis Pharmaceuticals's earnings are forecast to decrease from -$4.45 per share to -$4.44 per share next year representing a decrease of -62.01%.

  • When is Apellis Pharmaceuticals's Earnings Date?

    Apellis Pharmaceuticals's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.37% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 4.03% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock